Nicholas Plant > Dentons > London, England > Lawyer Profile

Dentons
ONE FLEET PLACE
LONDON
EC4M 7WS
England
Nicholas Plant photo

Work Department

Corporate.

Position

Nicholas is co-leader of Dentons’ global private equity practice.

He has more than 20 years’ experience advising on both domestic and cross-border leveraged buyouts and has led over £10 billion of LBOs in the last five years.

Nicholas has worked extensively for some of the leading private equity houses, including Apax, Blackstone, Centerbridge, CVC Capital Partners, Duke Street Capital, European Capital, Graphite Capital, Investcorp, Stonepeak Infrastructure Partners and ZQ Capital.

Career

Trained SJ Berwin 1998, qualified 2002. Partner in present firm since 2013. Secondee, Goldman Sachs London 2002; Associate, Hogan Lovells London 2002-04; Partner and Associate, SJ Berwin London 2004-13; Partner, Dentons UKMEA LLP London 2013 to date.

Education

Kings Secondary School, Canterbury; University of Southampton (1992 BA); American University in Washington DC (1993 MA).

Leisure

Grade 8 piano; Glyndebourne member; keen skier.

Lawyer Rankings

London > Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)

(Leading partners)

Nicholas PlantDentons

Boasting expertise across multiple sectors, Dentons acts for various investors and funds on a host of mid-market, multijurisdictional transactions. UK corporate head Neil Nicholson‘s recent engagements include a number of strategic investment deals in the tech sector. Nicholas Plant has considerable experience acting for multinational investors and funds on complex cross-border leveraged buyouts, as well as a number of mandates concerning African-focused PE funds. Stephen Levy acts as the global relationship partner to some of the firm’s most high-profile clients, while James Davison supports funds, portfolio companies and management teams across an array of PE-driven M&A deals. Vincent Leung is recognised for his extensive cross-border practice, with a strong track record in tech, life sciences and infrastructure deals.